Results 231 to 240 of about 419,158 (294)
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain". [PDF]
Oncol TherLozano V +7 more
europepmc +1 more source
The Economic Impact of the Pfizer and Fort Trumbull Development Projects [PDF]
Nandika Weerasinghe, Stan McMillen
core